Literature DB >> 12645936

ICOS+ Th cells produce distinct cytokines in different mucosal immune responses.

Kerstin Bonhagen1, Oliver Liesenfeld, Miguel J Stadecker, Andreas Hutloff, Klaus Erb, Anthony J Coyle, Martin Lipp, Richard A Kroczek, Thomas Kamradt.   

Abstract

T cell activation, differentiation and effector functions depend on signals delivered through the antigen-specific TCR and non-clonal costimulatory receptors on the T cell. Activated T cells express the inducible costimulator (ICOS). We examined the co-expression of ICOS with Th cytokines in mucosal immune responses. ICOS+CD4+ Th cells expressed strikingly different cytokines depending on the type of infection encountered and the cells' anatomical localization. In the Th2-dominated response to Schistosoma mansoni, ICOS expression of CD4+ cells isolated from the liver was strongly associated with the expression of IL-5, IL-10, IL-13, and T1/ST2, but not with the chemokine receptor CXCR5, a pattern consistent with Th2 effector cells. In the secondary lymphatic organs of schistosome-infected mice, ICOS expression was randomly correlated with Th2 effector-cytokines, but positively correlated with CXCR5 expression; a pattern consistent with follicular Th cells. In Th cells isolated from gut or liver of mice infected with Toxoplasma gondii, ICOS expression was positively correlated with IFN-gamma production. Finally, in the severe combined immunodeficiency transfer colitis model, ICOS expression was strongly positively associated with IFN-gamma and IL-2. Thus, ICOS appears to costimulate distinct effector functions in different immune responses, depending on factors such as the nature of the antigen encountered and localization and chronicity of the immune response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645936     DOI: 10.1002/immu.200310013

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells.

Authors:  Marko Janke; Esther J Witsch; Hans W Mages; Andreas Hutloff; Richard A Kroczek
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

2.  The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.

Authors:  Teresa Marafioti; Jennifer C Paterson; Erica Ballabio; Andreas Chott; Yasodha Natkunam; Manuel Rodriguez-Justo; Anne Plonquet; Socorro M Rodriguez-Pinilla; Wolfram Klapper; Martin-L Hansmann; Stefano A Pileri; Peter G Isaacson; Harald Stein; Miguel A Piris; David Y Mason; Philippe Gaulard
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

3.  Role for inducible costimulator in control of Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Mariana Vidric; Anna Tafuri Bladt; Umberto Dianzani; Tania H Watts
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

4.  The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells.

Authors:  Aurelie T Bauquet; Hulin Jin; Alison M Paterson; Meike Mitsdoerffer; I-Cheng Ho; Arlene H Sharpe; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-12-21       Impact factor: 25.606

5.  ICOS costimulation expands Th2 immunity by augmenting migration of lymphocytes to draining lymph nodes.

Authors:  Amanda G Tesciuba; Rebecca A Shilling; Monica D Agarwal; Hozefa S Bandukwala; Bryan S Clay; Tamson V Moore; Joel V Weinstock; Andrew A Welcher; Anne I Sperling
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

6.  Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.

Authors:  Ellen Marks; Martina Verolin; Anneli Stensson; Nils Lycke
Journal:  Infect Immun       Date:  2007-07-16       Impact factor: 3.441

7.  B7h (ICOS-L) maintains tolerance at the fetomaternal interface.

Authors:  Leonardo V Riella; Shirine Dada; Lola Chabtini; Brian Smith; Lei Huang; Pranal Dakle; Bechara Mfarrej; Francesca D'Addio; La-Tonya Adams; Nora Kochupurakkal; Andrea Vergani; Paolo Fiorina; Andrew L Mellor; Arlene H Sharpe; Hideo Yagita; Indira Guleria
Journal:  Am J Pathol       Date:  2013-04-08       Impact factor: 4.307

Review 8.  T-cell costimulation and coinhibition in atherosclerosis.

Authors:  Israel Gotsman; Arlene H Sharpe; Andrew H Lichtman
Journal:  Circ Res       Date:  2008-11-21       Impact factor: 17.367

9.  Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation.

Authors:  Marie Toussaint; David J Jackson; Dawid Swieboda; Anabel Guedán; Theodora-Dorita Tsourouktsoglou; Yee Man Ching; Coraline Radermecker; Heidi Makrinioti; Julia Aniscenko; Nathan W Bartlett; Michael R Edwards; Roberto Solari; Frédéric Farnir; Venizelos Papayannopoulos; Fabrice Bureau; Thomas Marichal; Sebastian L Johnston
Journal:  Nat Med       Date:  2017-05-01       Impact factor: 53.440

10.  B7h-expressing dendritic cells and plasma B cells mediate distinct outcomes of ICOS costimulation in T cell-dependent antibody responses.

Authors:  Kevin Larimore; Linda Liang; Sonia Bakkour; William C Sha
Journal:  BMC Immunol       Date:  2012-06-11       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.